Terahertz real-time release testing for pharmaceutical products

Lead Participant: TERAVIEW LIMITED

Abstract

The project will develop a new, rapid and non-destructive test instrument for predicting tablet efficacy and performance, based on direct measurements of tablet porosity using terahertz light. In so doing, we expect to contribute to manufacturing efficiency improvements in production of advanced solid dose medicines. Our technology will initially be marketed as a test which can work alongside existing methods (dissolution/disintegration and hardness testing) to improve tablet quality during the design process. The ultimate goal is to act as a real-time, in-line test and feedback mechanism as the industry moves towards Continuous Manufacturing.

Lead Participant

Project Cost

Grant Offer

TERAVIEW LIMITED £468,150 £ 327,705
 

Participant

GLAXOSMITHKLINE PLC £40,411 £ 20,206
UNIVERSITY OF CAMBRIDGE £225,317 £ 225,317
HUXLEY BERTRAM ENGINEERING LIMITED £228,808 £ 160,166
UNIVERSITY OF CAMBRIDGE

Publications

10 25 50